Delivery Order SPE2DB22D2005-SPE2DB24FJQC2
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order for JANUMET XR 50-1,000 MG TABLET 60S, valued at $4,772.88. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency. The award has an ultimate completion date of May 12, 2023 and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $4,419.18, is for the delivery of JANUMET XR 50-1,000 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract has a period of performance through February 1, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger...
This federal contract award, valued at $36,954.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, and has an ultimate completion date of June 6, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,546.26, is for the delivery of JANUMET XR 50-1,000 mg tablets. The contract has an ultimate completion date of November 6, 2023 and is a firm fixed-price delivery order. This contract award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA, valued at $999,999,999 and...
This federal contract award, valued at $1,437.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price delivery order. The contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $6,945.50, is for the supply of JANUMET XR 50-1,000 MG tablets. The contract has an ultimate completion date of August 5, 2024 and is a firm fixed-price delivery order. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of JANUMET XR 100-1,000 MG tablets, with a ceiling value of $1,667.78 and a performance period through November 16, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,744.17, is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of JANUMET XR 50-1,000 mg tablets in 1,000 count units. The contract has a ceiling value of $8,901.40 and an ultimate completion date of June 13, 2024. It was awarded on June 12, 2024 by the Medical Supply Chain division of the Defense agency. The contract does not have a set-aside designation and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,874.29 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of JANUMET XR 50-1,000 mg tablets in 60-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...